<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109282-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Apprentissage automatique pour le diagnostic num&#xE9;rique de la r&#xE9;sistance aux antimicrobiens</narrative>
   <narrative xml:lang="EN">Machine learning for digital diagnostics of antimicrobial resistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">If action is not taken, antimicrobial resistance (AMR) will cost $100 trillion and claim 10 million lives annually by 2050. The factors driving AMR extend beyond human healthcare, with implications in veterinary medicine, agriculture, and the environment. New and improved approaches for tackling AMR include better monitoring, rational drug use, different business models to generate antibiotics, innovation at all levels, and most importantly, a global approach. 

This project assembles a transnational team (Canada, China, Finland, France) to apply new machine learning approaches for faster diagnosis and better monitoring of resistance. The initial focus will be on two major global pathogens that have developed multi-drug resistance: Pseudomonas aeruginosa and Streptococcus pneumoniae. The research team will develop machine learning that can orient treatment selection by assessing the level of resistance, providing a rationale for generating novel antibiotics, and assisting in the surveillance of human and livestock antimicrobial resistance.  

This is one of five IDRC-funded projects developed through the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), an international collaborative platform that coordinates global funding to support collaborative research and action on antimicrobial resistance. Through the JPIAMR, IDRC has partnered with 18 other donor agencies to fund innovative research projects on diagnostics and surveillance strategies, as well as tools and technologies that can be used to detect and monitor antimicrobial resistance in human, veterinary, and environmental settings, particularly in low- and middle-income countries.</narrative>
   <narrative xml:lang="FR">Si aucune mesure n&#x2019;est prise, la r&#xE9;sistance aux antimicrobiens (RAM) co&#xFB;tera 100 mille milliards de dollars et fera 10 millions de victimes par an d&#x2019;ici 2050. Les facteurs &#xE0; l&#x2019;origine de la RAM ne se limitent pas aux soins de sant&#xE9; humaine, mais elles ont des r&#xE9;percussions sur la m&#xE9;decine v&#xE9;t&#xE9;rinaire, l&#x2019;agriculture et l&#x2019;environnement. Les approches nouvelles et am&#xE9;lior&#xE9;es pour s&#x2019;attaquer &#xE0; la RAM comprennent une meilleure surveillance, l&#x2019;utilisation rationnelle des m&#xE9;dicaments, diff&#xE9;rents mod&#xE8;les commerciaux pour produire des antibiotiques, l&#x2019;innovation &#xE0; tous les niveaux et, surtout, une approche globale. 

Ce projet r&#xE9;unit une &#xE9;quipe transnationale (Canada, Chine, Finlande, France) pour appliquer de nouvelles approches d&#x2019;apprentissage automatique permettant un diagnostic plus rapide et un meilleur suivi de la r&#xE9;sistance. Dans un premier temps, l&#x2019;accent sera mis sur deux grands pathog&#xE8;nes mondiaux qui ont d&#xE9;velopp&#xE9; une multir&#xE9;sistance aux m&#xE9;dicaments : Pseudomonas aeruginosa et Streptococcus pneumoniae. L&#x2019;&#xE9;quipe de recherche &#xE9;laborera l&#x2019;apprentissage automatique qui peut orienter le choix du traitement en &#xE9;valuant le niveau de r&#xE9;sistance, en fournissant une justification pour la production de nouveaux antibiotiques et en aidant &#xE0; la surveillance de la r&#xE9;sistance aux antimicrobiens chez l&#x2019;homme et le b&#xE9;tail. 

Il s&#x2019;agit de l&#x2019;un des cinq projets financ&#xE9;s par le CRDI qui ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s dans le cadre de la Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), une plateforme collaborative internationale qui coordonne le financement mondial pour appuyer la recherche et l&#x2019;action concert&#xE9;es sur la r&#xE9;sistance aux antimicrobiens. Par l&#x2019;interm&#xE9;diaire de la JPIAMR, le CRDI s&#x2019;est associ&#xE9; &#xE0; 18 autres organismes donateurs pour financer des projets de recherche novateurs sur les strat&#xE9;gies, ainsi que les outils et les technologies de diagnostic et de surveillance pouvant servir &#xE0; la d&#xE9;tection et au suivi de la r&#xE9;sistance aux antimicrobiens chez les humains, les animaux et dans l&#x2019;environnement, en particulier dans les pays &#xE0; revenu faible et &#xE0; revenu interm&#xE9;diaire.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="15">
   <narrative xml:lang="EN">Institute of Microbiology</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Institute of Microbiology</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-03-01" type="2"></activity-date>
  <activity-date iso-date="2023-03-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-country code="CN" percentage="0"></recipient-country>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-03-20"></transaction-date>
   <value currency="CAD" value-date="2020-03-20">420800</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-20"></transaction-date>
   <value currency="CAD" value-date="2020-03-20">100050</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-100050</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">100050</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-25"></transaction-date>
   <value currency="CAD" value-date="2020-11-25">109433</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">-109433</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">109433</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-05-21"></transaction-date>
   <value currency="CAD" value-date="2021-05-21">74450</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Microbiology</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
